Les “petits-garçons DES” issus de “grands-mères distilbène” sont 40 à 50 fois plus exposés au risque de malformations du pénis
Une étude montre que les petits-enfants des femmes traitées avec l’hormone de synthèse Distilbène® DES, médicament prescrit aux femmes enceintes jusqu’à la fin des années 70 et sensé prevenir les fausses couches, sont 40 à 50 fois plus exposés au risque de malformations du pénis.
Endometriosis occurs when endometrial cells grow where they shouldn’t – in places other than the uterus lining. It is estimated that up to 10% of women, or more, suffer endometriosis. Some studies have recently indicated that molecules from plastic, that break down in heat, can mimic estrogen, and may contribute to hormone problems, such as endometriosis. The rate of endometriosis is estimated to be 80% greater in women exposed to DiEthylStilbestrol in utero.
Are you a probable DES Daughter?
See this Chart and establish how much Risk you face!
A study of daughters of women given diethylstilbestrol, synthetic estrogen, during pregnancy has found that exposure to the drug while in the womb is associated with many reproductive problems and an increased risk of certain cancers.
DES is definitely no a drug of the past : this chart highlights the increased health risks associated with DES exposure, compared to the risks for women who were not exposed to DES in the womb.
Want to know more about the pregnancy drug DiEthylStilbestrol?
New AFSSAPS DES survey and update
DES historical facts, current issues, risks associated with DES exposure, breast cancer risks, post adolescent psychiatric disorders, risks for the 3rd generation, DES pregnancy care.
DES Sons Numbers and Health Concerns
Although less is known about the consequences of diethylstilbestrol exposure in men than in women, important DES health concerns have been identified.
DES Sons Studies
The most common reported health issues in DES sons studies are epididymal cysts, testicular problems, testicular cancer, infertility, psychological and neurological effects.
Gender Identity and DES Exposure
Dr. Dana Beyer radio interview on the significant evidence linking prenatal Diethylstilbestrol DES exposure with gender identity and transsexual development.